Clinical Study Results
1. Study Name
What does this summary cover?
This summary shows the main results from one clinical study. The results are only for
this study. Other studies may find different results. Researchers and health authorities
look at the results of many studies to decide which medicines work best and are safest
for patients.
Title of the Study: A Multicenter Single-arm Extension Study to Characterize the
Long-term Safety of Cinacalcet Hydrochloride in the
Treatment of Secondary Hyperparathyroidism in Pediatric
Subjects with Chronic Kidney Disease on Dialysis
Brief Title: How Does Long-term Cinacalcet Use Affect Children with
Secondary Hyperparathyroidism Caused by Chronic Kidney
Disease?
Protocol Number: 20140159
devorppA
EU Trial Number 2014-003563-38
Other Identifiers NCT02341417
Date of This Summary 04 June 2018
2. Who Sponsored This Study?
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 USA
Phone (United States): +1 805-447-1000
Amgen Inc. is the sponsor of the study and manufactured cinacalcet, the investigational
medicine in this study. Amgen would like to thank everyone who participated in this
study or allowed their child to participate, and feels it is important to share the results of
this study.
1